InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: petemantx post# 338686

Monday, 01/04/2021 9:22:56 PM

Monday, January 04, 2021 9:22:56 PM

Post# of 403325
I am seriously hoping you are right Pete. I think Leo is wanting to get Brilacidin on the big stage and this is his chance.

Go Leo & IPIX!

I am now of the belief that our next PR will be upon completion of the trial. No real need for any interim data to be given out since the trial is so short and all such PRs would bring about is more derision as fluff and nonsense. No need giving any info to those that don't need it or would twist it.

I believe the trial is currently ongoing and fully underway with all patients enrolled. Figure that should have taken only as long as needed to do the admin work to admit them. They certainly didn't have to look hard to find them.

As such, I believe nothing this week in the way of news, possibly some late next week, but more likely one of the last 2 weeks of the month. I can wait as that will be the BIG ONE IMO as to PRs. We sink or swim with Brilacidin CV according to those results.

In the meantime, price varies at about the current levels with a small dip possible. Only thing it will accomplish is allow those shorting to dig a deeper hole IMO.

I have always heard in important trials that the less heard and the longer it takes to get the word is a good sign.

This is just my WAG.(so it wouldn't surprise me that much if something came about this week - I would laugh at myself as much as others would)


FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19


Brilacidin in a human lung cell line infected by SARS-CoV-2, achieved a high Selectivity Index rating of 426.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News